| Date Filed | Type | Description |
| 09/20/2022 |
SC 13D
| ARCH Venture Fund VIII, L.P. reports a 24.7% stake in Codiak Biosciences, Inc. |
| 02/08/2022 |
SC 13G/A
| ARCH Venture Fund VIII, L.P. has filed a Schedule 13D for Exit Filing)* Denali Therapeutics Inc. |
| 02/04/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2021 |
SC 13G
| ARCH Venture Fund VIII, L.P. has filed a Schedule 13D for * Metacrine, Inc. |
| 02/02/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| ARCH Venture Fund VIII, L.P. reports a 8.9% stake in Scholar Rock Holding Corporation |
| 02/13/2020 |
SC 13G/A
| ARCH Venture Fund VIII, L.P. reports a 11.1% stake in Denali Therapeutics Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/06/2019 |
SC 13D
| ARCH Venture Fund VIII, L.P. reports a 19.9% stake in Sienna Biopharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G
| ARCH Venture Fund VIII, L.P. reports a 10.5% stake in Scholar Rock Holding Corporation |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2018 |
SC 13G
| ARCH Venture Fund VIII, L.P. reports a 12.3% stake in Denali Therapeutics Inc. |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2016 |
SC 13G/A
| ARCH Venture Fund VIII, L.P. reports a 8.8% stake in Kura Oncology, Inc. |
| 03/13/2015 |
SC 13G
| ARCH Venture Fund VIII, L.P. reports a 9.3% stake in Kura Oncology, Inc. |